A free guide to identifying, prioritising and managing uncertainty across brand, launch and medical plans
Most pharma plans are built on assumptions of predictability. That is a problem.
In reality, every brand plan, launch plan and medical plan is shaped by events with unknown outcomes. Competitor trial results. Payer decisions. Guideline updates. Regulatory shifts. The organisations that succeed are not those that predict the future correctly. They are those that plan for multiple futures deliberately.
This toolkit gives pharma marketing and medical affairs professionals a practical framework for doing exactly that.
What you will find in this guide
The Risk & Uncertainty Toolkit distils the core frameworks from CELforPharma's course Managing Uncertainty & Risk in Pharma Marketing & Medical Planning, taught by Dr Neal Hansen and Mitchell Cooke of Align Strategy. It covers three tools to be leveraged via a four-step process, presented as a concise visual reference you can use in your own planning cycles.
Want to take this guide with you?
Download the complete toolkit below 👇
What the toolkit covers:
- The difference between uncertainty and risk, and why the distinction matters for planning
- The 4-Step Uncertainty Management Process: from identifying unknowns to acting on them
- Tool 1: Uncertainty Mapping via Situational Analysis and how to surface your base-case assumption
- Tool 2: Risk Prioritisation and how to assess likelihood, business impact and your ability to address identified risks
- Tool 3: Scenario Planning and how to consolidate complex uncertainties into manageable future worlds
- How to communicate uncertainty convincingly to internal stakeholders
What is the 4-Step Uncertainty Management Process in pharma?
The 4-Step Uncertainty Management Process is a structured approach to embedding risk and uncertainty planning into pharma marketing and medical planning cycles.
Step 1: Identify.
Map the full range of uncertainties via situational analysis, uncovering near-term (1-3 years), mid-term (3-5 years), and long-term (5+ years), as well as internal, market, and competitive uncertainties. Define the base-case: the most probable future outcome of the uncertainties given everything currently known.
Step 2: Prioritise.
Identify alternative (negative) outcomes to the base-case - these are your risks. Assess each potential risk by likelihood of occurrence and business impact. Use a priority matrix to focus resources on the risks that are high-impact (even if likelihood of occurring is low). Then assess your ability to address each risk, whether it can be managed proactively within strategy or only responded to reactively.
Step 3: Plan.
Where multiple uncertainties interact, which is common in mid- to long-term planning, use scenario planning to consolidate outcomes into thematic future worlds. Each scenario should reflect distinctly different strategic implications, so that whichever future plays out, the organisation is ready to pivot.
Step 4: Act.
Pressure-test the base-case strategy, review market-shaping activities, build contingency plans for low-probability but high-impact scenarios, and put in place a continuous, targeted monitoring plan.
What are the three core tools for managing uncertainty in pharma planning?
- Uncertainty Mapping identifies and organises all relevant uncertainties that exist within a given planning context. Conducted as part of a situational analysis, it produces a base-case assumption that anchors the core strategy. Uncertainty mapping should be conducted for all planning types: brand and portfolio plans, launch plans, medical plans, country plans and lifecycle management plans.
- Risk Prioritisation takes the potential negative outcomes (i.e., risks) of the uncertainties identified and evaluates them by two criteria: likelihood of occurrence and business impact. Risks in the high-impact, high-likelihood quadrant are critical to address. The process also assesses whether each risk is strategic (can be anticipated and mitigated within core strategy), contingency-based (requires a rapid-response plan), or an acceptance risk (must be tracked but worked around).
- Scenario Planning is used when multiple uncertainties interact and individual risk assessment is insufficient, typically for planning horizons of three years or more. It consolidates uncertainties into a small number of thematic scenarios, each representing a different plausible future. Each scenario defines the overall future world, core stakeholder assumptions, treatment algorithm implications, drivers and barriers, and key market disruptors.
Who should use this toolkit?
This toolkit is designed for pharma professionals who own or contribute to planning at any level:
- Brand and portfolio managers building annual or multi-year brand plans
- Launch excellence and commercial excellence teams preparing for product launches
- Medical affairs professionals developing medical plans and evidence generation strategies
- Regional and global strategic planners working across multiple markets and longer time horizons
It is relevant across all lifecycle stages, from early development through to loss of exclusivity planning.
"Communicating uncertainty alone is useless. Communicating uncertainty must include how you plan to manage those uncertainties. It is only through the communication of these plans that you will build credibility and confidence in your stakeholders."
From the course Managing Uncertainty & Risk in Pharma Marketing & Medical Planning
Download the toolkit
The Risk & Uncertainty Toolkit is a free resource for pharma planning professionals, drawn from the curriculum of CELforPharma's course Managing Uncertainty & Risk in Pharma Marketing & Medical Planning, developed by Align Strategy.
Ready to Go Deeper?
Continue your learning from Neal and Mitchell
If you’d like to learn more from Neal and Mitchell, CELforPharma also offers a 1-day, hands-on course where you'll:
- Learn a structured approach to identifying and categorising uncertainty and risk
- Gain a practical framework to prioritise and follow up on risk items
- Understand how to handle uncertainty based on risk profile and business impact
- Improve how you communicate uncertainty to internal stakeholders
Managing Uncertainty & Risk in Pharma Marketing & Medical Planning
With Dr Neal Hansen & Mitchell Cooke
Don’t miss the latest insights from our expert faculty
Subscribe to our newsletter to:
- Stay on top of the latest expert insights
- Receive invitations to upcoming educational webinars
- Get updates on our courses and training programmes